Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 15, 2023
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
Tue, March 14, 2023
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
Sean Kim Initiated (TRVI) at Strong Buy and Held Target at $7 on, Mar 14th, 2023
Sean Kim of JonesTrading, Initiated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $7 on, Mar 14th, 2023.
Sean has made no other calls on TRVI in the last 4 months.
There is 1 other peer that has a rating on TRVI. Out of the 1 peers that are also analyzing TRVI, 0 agree with Sean's Rating of Hold.
This is the rating of the analyst that currently disagrees with Sean
- Thomas Smith of "SVB Leerink" Initiated at Buy and Held Target at $6 on, Tuesday, November 22nd, 2022
